Board Meeting Intimation for Results & Closure of Trading Window

Bacil Pharma Ltd has informed BSE that the Meeting of Board of Directors of the Company will be held on November 15, 2016, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended 30th September, 2016 as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, performance review and any business proposal and to consider any other matter with the permission of the chair.

Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company would remain closed for all the employees/Directors/designated persons of the Company from November 04, 2016 to November 17, 2016 (both days inclusive).

Pdf Link: >Board Meeting Intimation for Results & Closure of Trading Window

Source : BSE - >

Published on November 03, 2016


This article is closed for comments.
Please Email the Editor